{"id":10314,"date":"2020-05-22T13:00:06","date_gmt":"2020-05-22T11:00:06","guid":{"rendered":"https:\/\/idibell.cat\/en\/?p=10314"},"modified":"2020-05-26T17:25:32","modified_gmt":"2020-05-26T15:25:32","slug":"the-hub-ico-idibell-biobank-responds-to-the-pandemic-and-creates-a-collection-of-covid-19-samples-for-research","status":"publish","type":"post","link":"https:\/\/idibell.cat\/en\/2020\/05\/the-hub-ico-idibell-biobank-responds-to-the-pandemic-and-creates-a-collection-of-covid-19-samples-for-research\/","title":{"rendered":"The HUB-ICO-IDIBELL Biobank responds to the pandemic and creates a collection of COVID-19 samples for research"},"content":{"rendered":"

The SARS-CoV-2 pandemic, and the impact on health at the international level, has highlighted the need to promote research to obtain associated biological and clinical information for the development of treatments that help to mitigate the widespread contagion scenario.<\/p>\n

The HUB-ICO-IDIBELL Biobank in collaboration with the Bellvitge University Hospital (HUB) and IDIBELL launched in March the prospective collection of the COVID-19 biobank, consisting of sera, plasmas, DNA and RNA from patients confirmed for SARS-CoV-2 to make it available to the scientific community. In addition, the HUB-ICO-IDIBELL Biobank participates in the processing and preservation of samples from competitive COVID-19 projects and in various clinical trials. For this reason, various prospective and restricted circuits have been activated in which the extractions of the samples of the COVID-19 patients are scheduled and sent to the Biobank for processing and preservation. IDIBELL has created a COVID-19 Committee that will help evaluate the transfer of COVID-19 biobank samples to high impact research projects.<\/p>\n

The Biobank also offers support services to researchers in ethical and legal compliance aspects in the use of human samples in research.<\/p>\n

We remember the importance of:<\/p>\n